Literature DB >> 26997609

The management of pregnancy and delivery in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Angela Pipitone1, Donna B Raval2, Jessica Duis1, Hilary Vernon1, Regina Martin1, Ada Hamosh1, David Valle1, Meral Gunay-Aygun1.   

Abstract

3-hydroxy-3-methylglutaric (HMG)-CoA lyase is required for ketogenesis and leucine degradation. Patients with HMG-CoA lyase deficiency typically present with hypoketotic hypoglycemia and metabolic acidosis, which can be fatal if untreated. The patient is a 28-year-old female with HMG-CoA lyase deficiency who presented at 4 weeks gestation for prenatal care. Protein intake as well as carnitine supplementation were gradually increased to support maternal and fetal demands up to 65 g per day for protein and 80 mg/kg/day for carnitine. Fetal growth was appropriate. At 36 5/7 weeks, she presented with spontaneous rupture of membranes. Twice maintenance 10% glucose-containing intravenous fluids were initiated. During labor, vomiting and metabolic acidosis developed. Delivery was by cesarean. Preeclampsia developed postpartum. The patient recovered well and was discharged home on postpartum day 5. Stress of pregnancy and labor and delivery can lead to metabolic decompensation in HMG-CoA lyase deficiency. Patients should be monitored closely by a biochemical geneticist, dietitian, and high-risk obstetrician at a tertiary care center during their pregnancy. Fasting should be avoided. Intravenous 10% glucose-containing fluids should be provided to prevent catabolism and metabolic decompensation during labor and delivery.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  3-hydroxy-3-methylglutaric CoA lyase deficiency; HMG-CoA lyase deficiency; pregnancy

Mesh:

Substances:

Year:  2016        PMID: 26997609      PMCID: PMC5702463          DOI: 10.1002/ajmg.a.37620

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

Review 1.  Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review.

Authors:  Donna B Raval; Melissa Merideth; Jennifer L Sloan; Nancy E Braverman; Robert L Conway; Irini Manoli; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2015-01-08       Impact factor: 4.982

2.  A series of pregnancies in women with inherited metabolic disease.

Authors:  Janneke G Langendonk; Jonathan C P Roos; Lindsay Angus; Monique Williams; François P J Karstens; Johannes B C de Klerk; Charlé Maritz; Tawfeg Ben-Omran; Catherine Williamson; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-15       Impact factor: 4.982

Review 3.  Ketone body metabolism and its defects.

Authors:  Toshiyuki Fukao; Grant Mitchell; Jörn Oliver Sass; Tomohiro Hori; Kenji Orii; Yuka Aoyama
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

  3 in total
  4 in total

1.  Successful Management of Pregnancies in Patients with Inherited Disorders of Ketone Body Metabolism.

Authors:  Raashda Ainuddin Sulaiman; Maha Al-Nemer; Rubina Khan; Munirah Almasned; Bedour S Handoum; Zuhair N Al-Hassnan
Journal:  JIMD Rep       Date:  2017-05-10

2.  Favourable Outcome in Two Pregnancies in a Patient with 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency.

Authors:  David Santosa; Markus G Donner; Stephan Vom Dahl; Markus Fleisch; Thomas Hoehn; Ertan Mayatepek; Katrin Heldt; Tim Niehues; Dieter Häussinger
Journal:  JIMD Rep       Date:  2017-02-21

Review 3.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

4.  3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces.

Authors:  Sarah C Grünert; Jörn Oliver Sass
Journal:  Orphanet J Rare Dis       Date:  2020-02-14       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.